KARA, E. Et Al. 2004. Effects of rofecoxib, a selective cyclooxygenase-2 inhibitor, on endothelial dysfunction, lipid peroxidation, and hepatocyte morphology in rats with sepsis-induced liver damage. Current Therapeutic Research - Clinical and Experimental , vol.65, no.3 , 278-291.

KARA, E., Var, A., Vatansever, S., Cilaker, S., KAYA, Y., & COŞKUN, T., (2004). Effects of rofecoxib, a selective cyclooxygenase-2 inhibitor, on endothelial dysfunction, lipid peroxidation, and hepatocyte morphology in rats with sepsis-induced liver damage. Current Therapeutic Research - Clinical and Experimental , vol.65, no.3, 278-291.

KARA, ERAY Et Al. "Effects of rofecoxib, a selective cyclooxygenase-2 inhibitor, on endothelial dysfunction, lipid peroxidation, and hepatocyte morphology in rats with sepsis-induced liver damage," Current Therapeutic Research - Clinical and Experimental , vol.65, no.3, 278-291, 2004

KARA, ERAY Et Al. "Effects of rofecoxib, a selective cyclooxygenase-2 inhibitor, on endothelial dysfunction, lipid peroxidation, and hepatocyte morphology in rats with sepsis-induced liver damage." Current Therapeutic Research - Clinical and Experimental , vol.65, no.3, pp.278-291, 2004

KARA, E. Et Al. (2004) . "Effects of rofecoxib, a selective cyclooxygenase-2 inhibitor, on endothelial dysfunction, lipid peroxidation, and hepatocyte morphology in rats with sepsis-induced liver damage." Current Therapeutic Research - Clinical and Experimental , vol.65, no.3, pp.278-291.

@article{article, author={ERAY KARA Et Al. }, title={Effects of rofecoxib, a selective cyclooxygenase-2 inhibitor, on endothelial dysfunction, lipid peroxidation, and hepatocyte morphology in rats with sepsis-induced liver damage}, journal={Current Therapeutic Research - Clinical and Experimental}, year=2004, pages={278-291} }